N-acetylcysteine and other sulfur-donors as a preventative and adjunct therapy for covid-19

HIGHLIGHTS

• who: N-Acetylcysteine and collaborators from the Catalysis and Peptide Research Unit, University of KwaZulu-Natal, Westville Campus, Durban, South Africa have published the research work: N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19, in the Journal: Advances in Pharmacological and Pharmaceutical Sciences of 10/08/2022
• what: With ample evidence in the scientific literature that coronavirus disease 2019 (COVID19) is related to epithelial and endothelial dysfunction preserving the glycocalyx should be the main focus of any COVID-19 treatment protocol. The authors provide a short summary here . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.